(Reuters) - Genetic Technologies Ltd's (GENE.O) (GTG.AX) U.S.-listed shares closed up 30 percent on Friday, capping a two-and-a-half week spate of heavy trading during which its market valuation increased by 533 percent.
U.S. shares in the Australian genetic testing company closed at $8.04 on Friday on no apparent news during the day. They rose as much as 54.6 percent earlier in the session to touch a nearly 12-month high of $9.49 per share.
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper8
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth15
07:16 Aroldis Chapman Acquired by Yankees in Five-Year, $86 Million Deal17
16:37 Fitbit acquires software assets from rival Pebble14